Please use this identifier to cite or link to this item: https://doi.org/10.1055/s-0030-1260460
DC FieldValue
dc.titleFormation of functionalized cyclopentenes via catalytic asymmetric [3+2] cycloaddition of acrylamides with an allenoate promoted by dipeptide-derived phosphines
dc.contributor.authorHan, X.
dc.contributor.authorWang, S.-X.
dc.contributor.authorZhong, F.
dc.contributor.authorLu, Y.
dc.date.accessioned2014-06-23T05:39:57Z
dc.date.available2014-06-23T05:39:57Z
dc.date.issued2011
dc.identifier.citationHan, X., Wang, S.-X., Zhong, F., Lu, Y. (2011). Formation of functionalized cyclopentenes via catalytic asymmetric [3+2] cycloaddition of acrylamides with an allenoate promoted by dipeptide-derived phosphines. Synthesis (12) : 1859-1864. ScholarBank@NUS Repository. https://doi.org/10.1055/s-0030-1260460
dc.identifier.issn00397881
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/76211
dc.description.abstractAcrylamides derived from 3,5-dimethyl-1H-pyrazole are employed in the asymmetric [3+2] cycloaddition with the allenoate, tert-butyl buta-2,3-dienoate, for the first time. d-Threonine-l-tert-leucine-based bifucntional phosphines are effective catalysts for the above reactions, affording regiospecific [3+2]-annulation products in excellent yields and with moderate enantioselectivities. © Georg Thieme Verlag Stuttgart - New York.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1055/s-0030-1260460
dc.sourceScopus
dc.subject[3+2] cycloaddition
dc.subjectamino acids
dc.subjectbifunctional phosphine catalysts
dc.subjectchiral phosphines
dc.typeArticle
dc.contributor.departmentCHEMISTRY
dc.description.doi10.1055/s-0030-1260460
dc.description.sourcetitleSynthesis
dc.description.issue12
dc.description.page1859-1864
dc.description.codenSYNTB
dc.identifier.isiut000291302900007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.